Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab
- 19 February 2021
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 94 (1), e13031
- https://doi.org/10.1111/sji.13031
Abstract
Background Severe eosinophilic asthma (SEA) has been associated with T‐helper type 2 (Th2) inflammatory response. A good understanding of T cell functions in asthma is important for therapy, especially in the choice of biological treatments for severe cases. Mepolizumab, an IL‐5 antagonist, is indicated for the treatment of severe asthma. Regulatory T cells (Tregs) suppress inflammation by secreting cytokines that inhibit Th2 cell proliferation. Objective We investigated peripheral Treg, CD4, CD8, CD19 and NK cell percentages and their relationship to clinical and functional parameters, including peripheral eosinophils, before and after anti‐IL5 treatment. Materials and Methods Subjects were 14 adult SEA patients (9 male, 54.1±11.6 years), treated with mepolizumab, and 10 controls. T cells (CD4 and CD8), CD19, NK and Tregs were evaluated by flow cytometry. Results Comparison of lung function parameters before and after treatment with mepolizumab (T0 and T1) showed an increase in FEV1, FEV1/FVC ratio and a reduction in blood eosinophil percentages. CD8 and CD16/56+CD3+ were significantly higher in SEA patients than controls (p=0.04 and p=0.03, respectively). A decrease in CD45+, CD8+ and CD16/56+CD3+ cell percentages was observed between T0 and T1 (p=0.02, p=0.04, p=0.03 respectively). A significant increase in Treg percentages (p=0.0001) was recorded between T0 and T1. Conclusions Mepolizumab therapy was found to modulate immune response, restoring immune balance in patients with SEA.Keywords
This publication has 38 references indexed in Scilit:
- Role of NKT cells in allergic asthmaCurrent Opinion in Immunology, 2010
- Data analysis in flow cytometry: The future just startedCytometry Part A, 2010
- Association between Sputum Natural Killer T Cells and Eosinophilic Airway Inflammation in Human AsthmaInternational Archives of Allergy and Immunology, 2010
- Regulatory T cells in many flavors control asthmaMucosal Immunology, 2010
- Emerging Roles of T Helper Subsets in the Pathogenesis of AsthmaImmunological Investigations, 2010
- Regulatory T Cells in AsthmaImmunity, 2009
- Natural killer T cells and the regulation of asthmaMucosal Immunology, 2009
- CD8+ T cells in asthma: Friend or foe?Pharmacology & Therapeutics, 2009
- NKT Cells in the Induced Sputum of Severe AsthmaticsMediators of Inflammation, 2006
- Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia.The Journal of Experimental Medicine, 1995